Lindner Center of Hope

Mason, Ohio 45040

2 studies enrolling now · 29 studies all time

What they study most

Binge Eating Disorder, Bipolar, Bipolar Depression, Bipolar Disorder, Borderline Personality Disorder, Bulimia Nervosa, Depression, Depression - Major Depressive Disorder, Depressive Disorder, Major, Intermittent Explosive Disorder, Major Depressive Disorder, Major Depressive Episode

Studies at this site

• Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains — Recruiting now
• E-diary vs Paper Diary in Binge Eating Disorder — Recruiting now
• A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant — Completed
• 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression — Completed
• Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated) — Completed
• A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder — Completed
• Medibio DDA Confirmatory Performance Study — Completed
• Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder — Completed
• Solriamfetol in Binge Eating Disorder — Status unconfirmed
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• Open Label Extension in Adults With Binge Eating Disorder (BED) — Completed
• Dasotraline Binge Eating Disorder Extension Study — Completed
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) — Completed
• Open Label Extension for GLYX13-C-202, NCT01684163 — Stopped early
• Dasotraline Binge Eating Disorder Study — Completed
• Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED) — Completed
• Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder — Completed
• Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder — Completed
• Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects — Status unconfirmed
• Armodafinil in Binge Eating Disorder (BED) — Completed
• N-acetylcysteine in the Treatment of Bulimia Nervosa — Stopped early
• Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression — Stopped early
• N-acetylcysteine in Bulimia Nervosa — Stopped early
• A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression — Completed
• Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity — Completed
• Sodium Oxybate in the Treatment of Binge Eating Disorder — Completed
• Acamprosate in the Treatment of Binge-Eating Disorder — Completed